Watson Labs

Last updated

Watson Labs may refer to:

Thomas J. Watson Research Center research institute in Yorktown Heights, New York, USA

The Thomas J. Watson Research Center is the headquarters for IBM Research. The center comprises two sites, with its main laboratory in Yorktown Heights, New York, U.S., 38 miles (61 km) north of New York City and with offices in Cambridge, Massachusetts.

Related Research Articles

The Anatomical Therapeutic Chemical (ATC) Classification System is a drug classification system that classifies the active ingredients of drugs according to the organ or system on which they act and their therapeutic, pharmacological and chemical properties. It is controlled by the World Health Organization Collaborating Centre for Drug Statistics Methodology (WHOCC), and was first published in 1976.

James Watson American molecular biologist, geneticist, and zoologist

James Dewey Watson is an American molecular biologist, geneticist and zoologist. In 1953, he co-authored with Francis Crick the academic paper proposing the double helix structure of the DNA molecule. Watson, Crick, and Maurice Wilkins were awarded the 1962 Nobel Prize in Physiology or Medicine "for their discoveries concerning the molecular structure of nucleic acids and its significance for information transfer in living material".

Watson may refer to:

The pharmaceutical industry is one of the leading industries in the People's Republic of China, covering synthetic chemicals and drugs, prepared Chinese medicines, medical devices, apparatus and instruments, hygiene materials, packing materials, and pharmaceutical machinery.

Janssen Pharmaceutica is a pharmaceutical company headquartered in Beerse, Belgium. It was founded in 1953 by Paul Janssen.

Monash University, Parkville campus pharmacy faculty of Monash University

Monash University, Parkville campus is a campus of Monash University, located in Parkville, Victoria, Australia. It is home to the Faculty of Pharmacy and Pharmaceutical Sciences, previously known as the Victorian College of Pharmacy. A centre of research and teaching, it is particularly well known for its research in drug development and formulation science, including the discovery and development of the world's first successful anti-influenza drug, Relenza. In international rankings, it is ranked as the number one school of pharmacy and pharmacology in Australia and the equal fourth best in the world alongside King's College London.

Actavis pharmaceutical company

Actavis Generics is a global pharmaceutical company focused on acquiring, developing, manufacturing and marketing branded pharmaceuticals, generic and over-the-counter medicines, and biologic products. Actavis has a commercial presence across approximately 100 countries. The company has global headquarters in Dublin, Ireland and administrative headquarters in Parsippany-Troy Hills, New Jersey, United States.

John Watson Funder is an Australian medical researcher.

The Ministry of Chemicals and Fertilizers in India is the administrative unit of three departments namely:-

Silodosin chemical compound

Silodosin (trade names Rapaflo, Silodyx, Rapilif, Silodal, Sildoo Urief, Thrupas, Urorec is a medication for the symptomatic treatment of benign prostatic hyperplasia. It acts as an α1-adrenoceptor antagonist with high uroselectivity.

Truven Health Analytics

Truven Health Analytics is a IBM Watson Health Company that provides healthcare data and analytics services. It provides information, analytic tools, benchmarks, research, and services to the healthcare industry, including hospitals, government agencies, employers, health plans, clinicians, pharmaceutical, biotech and medical device companies.

Sun Pharmaceutical Indian multinational pharmaceutical company

Sun Pharmaceutical Industries Limited is an Indian multinational pharmaceutical company headquartered in Mumbai, Maharashtra that manufactures and sells pharmaceutical formulations and active pharmaceutical ingredients (APIs) primarily in India and the United States. The company offers formulations in various therapeutic areas, such as cardiology, psychiatry, neurology, gastroenterology and diabetology. It also provides APIs such as warfarin, carbamazepine, etodolac, and clorazepate, as well as anti-cancers, steroids, peptides, sex hormones, and controlled substances.

Watson (computer) artificial intelligence computer system made by IBM

Watson is a question-answering computer system capable of answering questions posed in natural language, developed in IBM's DeepQA project by a research team led by principal investigator David Ferrucci. Watson was named after IBM's first CEO, industrialist Thomas J. Watson.

The pharmaceutical industry in the United Kingdom directly employs around 73,000 people and in 2007 contributed £8.4 billion to the UK's GDP and invested a total of £3.9 billion in research and development. In 2007 exports of pharmaceutical products from the UK totalled £14.6 billion, creating a trade surplus in pharmaceutical products of £4.3 billion.

GW Pharmaceuticals is a British biopharmaceutical company known for its multiple sclerosis treatment product nabiximols which was the first natural cannabis plant derivative to gain market approval in any country. Another cannabis-based product, Epidiolex, for treatment of epilepsy, was approved for treatment of epilepsy in 2018.

HortaPharm B.V. is a cannabis research and development business in the Netherlands.

Yoshua Bengio Canadian computer scientist

Yoshua Bengio is a Canadian computer scientist, most noted for his work on artificial neural networks and deep learning. He was a co-recipient of the 2018 ACM A.M. Turing Award for his work in deep learning. He is a professor at the Department of Computer Science and Operations Research at the Université de Montréal and scientific director of the Montreal Institute for Learning Algorithms (MILA).

Allergan plc is an Irish–tax registered pharmaceutical company that acquires, develops, and markets brand name drugs, and in 2017 generated 80% net sales from the U.S. healthcare system. Allergan plc was formed in February 2015 when Irish–registered Actavis plc acquired U.S.–registered Allergan, Inc., and assumed the Allergan name. Actavis was a 2013 U.S. corporate tax inversion who moved to Ireland to avoid U.S. taxes on their income, almost all of which came from the U.S. healthcare system. Actavis used the Irish low-tax corporate system to acquire large U.S. pharmaceutical firms, and redomicile them to Ireland. In 2016, the U.S. blocked Actavis from executing what would have been the largest corporate tax inversion in history with Pfizer.